BioCentury
ARTICLE | Company News

Cempra grants Toyama Japanese rights to solithromycin

May 14, 2013 12:26 AM UTC

Cempra Inc. (NASDAQ:CEMP) granted Toyama Chemical Co. Ltd. exclusive rights to develop and commercialize solithromycin in Japan. The fluoroketolide/macrolide antibiotic is in Phase III testing to trea...